Stellanin, 3%, 20 g

• 1,3-diethylbenzimidazolium triiodide - 3.0 g  

• povidone (low molecular weight polyvinylpyrrolidone),
• dimexide,
• glycerol (glycerin),
• petrolatum

Pharmaceutical group:  

A drug with anti-inflammatory, antimicrobial and tissue regeneration effects.

Pharmaceutical action: 

The active component of Stellanin is 1.3-diethylbenzimidazolium triiodide. The mechanism of the pharmacological activity of the drug lies in the direct regenerative action of 1.3-diethylbenzimidazolium on damaged skin. Active iodine, which is part of the drug, inactivates the proteins of the bacterial wall and enzyme proteins of bacteria, thereby providing a bactericidal effect.

Stellanin protects the wound surface from infections, suppresses the course of the infection process and promotes healing.
The drug has a wide range of antibacterial activity.

Bacteria Staphylococcus aureus, Clostridium dificille, Pseudomonas aeruginosa, Klebsiella pneumoniae, Streptococcus viridans, Streptococcus haemolyticus, Proteus mirabilis, Escherichia coli, Neisseria spp. Are susceptible to Stellanin; fungi Candida albicans and some other pathogens.

Pharmacokinetics: 

Stellanin ointment:

Systemic absorption of the active substance is absent even with damaged skin, however, therapeutic concentrations of the drug are present in the wound.

• Bedsores;
• trophic ulcers of the lower extremities;
• burns of I and II degrees;
• abrasions, cuts, scratches, cracks, scratches, incl. after insect bites;
• additional treatment of aseptic postoperative wounds (after excision, coagulation, episiotomy, for the treatment of cracks in the skin, wounds and sutures);
• acceleration of engraftment of a skin graft.

• Thyroid adenoma;
• thyrotoxicosis;
• acute renal failure;
• simultaneous therapy with radioactive iodine;
• children under 18;
• I trimester of pregnancy;
• hypersensitivity to drug components.

Carefully. Chronic renal failure, II and III trimesters of pregnancy, lactation.

In rare cases, allergic skin reactions (itching, flushing of the skin) are possible, in the event of which the drug should be discontinued.

Do not use the drug in combination with other antiseptic agents containing mercury, oxidizing agents, alkalis and cationic surfactants.
In the presence of blood, the bactericidal effect of the drug may decrease.

The drug is applied to the damaged skin surface so that the skin area is completely covered with the drug. The duration and frequency of application of the drug depends on the severity of the disease and the localization of the process. The daily dose should not exceed 10 g. It is possible to use occlusive dressings and a patch.

When treating granulating burns, wounds and trophic ulcers with weak exudation, the drug is applied in a uniform layer 1-1.5 mm thick so that the entire affected surface is covered with ointment, and a sterile gauze bandage is applied. 

Dressings are changed once every 1-2 days in the treatment of burns and 1-2 times / day. in the treatment of wounds and trophic ulcers. With an open method of treating burns, the drug is applied 1-2 times / day. The duration of treatment is determined by the dynamics of wound epithelialization.

For minor skin lesions (abrasions, cuts, scratches, cracks, scratches), the drug is applied in a thin layer to the affected surface 2 times / day.

Overdose cases are not described.

In case of accidental ingestion of the drug inside, nausea and vomiting may occur.

It is necessary to rinse the stomach and consult a doctor, if necessary, symptomatic treatment is performed.

The ointment should not be applied to mucous membranes.

In case of contact with eyes or mucous membranes, rinse with warm water.

Ointment.